Wms Partners, LLC Bio Techne Corp Transaction History

Wms Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$322.67 - $449.65 $200,378 - $279,232	-621 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$353.85 - $487.79 $717,607 - $989,238	-2,028 Reduced 76.56%	621 $269,000
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $233,092 - $268,305	511 Added 23.9%	2,649 $1.37 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $286,941 - $347,577	645 Added 43.2%	2,138 $1.04 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $20,529 - $23,863	-53 Reduced 3.43%	1,493 $672,000
Q4 2020 Feb 17, 2021	BUY	$246.9 - $321.87 $19,258 - $25,105	78 Added 5.31%	1,546 $491,000
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $3,251 - $3,961	14 Added 0.96%	1,468 $364,000
Q2 2020 Aug 12, 2020	BUY	$185.43 - $279.56 $12,980 - $19,569	70 Added 5.06%	1,454 $384,000
Q3 2019 Nov 07, 2019	BUY	$183.56 - $216.72 $63,328 - $74,768	345 Added 33.21%	1,384 $271,000
Q2 2019 Aug 13, 2019	BUY	$188.72 - $215.43 $196,080 - $223,831	1,039 New	1,039 $217,000

604

153M

171K

56.9K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.13B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wms Partners, LLC with notifications on news.